The Future Of Leukemia Treatment: No Chemotherapy And No Side-Effects
Wednesday, March 19, 2014 - 15:30
in Health & Medicine
Patients with terminal forms of leukemia and lymphoma who have run out of treatment options could still aid science - a Phase 1 trial into a new class of BTK (Bruton's Tyrosine Kinase) inhibiting drugs at Derriford Hospital in Plymouth. If it works, the new drug will improve a patients' life expectancy and quality of life by putting an end to chemotherapy with no side effects. read more